GIM
RCEL icon

Granahan Investment Management’s Avita Medical RCEL Stock Holding History

Granahan Investment Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-25,782
Closed -$219K – 186
2022
Q1 		$219K Buy
25,782
+4,050
+19% +$37.3K 0.01% 177
2021
Q4 		$260K Buy
21,732
+5,825
+37% +$88.8K 0.01% 184
2021
Q3 		$282K Buy
15,907
+3,092
+24% +$58.3K 0.01% 193
2021
Q2 		$263K Buy
+12,815
New +$253K ﹤0.01% 193

Other funds holding RCEL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Granahan Investment Management's RCEL Position: Q2 2022 in Review

Granahan Investment Management sold out of Avita Medical (RCEL) in Q2 2022, closing a stake of 25,782 shares — an estimated $219K sold.

Granahan Investment Management first reported a position in RCEL in Q2 2021 and held it in 4 quarters. The position peaked at $282K in Q3 2021. 56 funds tracked by Wall St. Rank hold RCEL as of Q2 2022.

  • Granahan Investment Management reported no remaining Avita Medical position as of Q2 2022 after selling out during the quarter.
  • Granahan Investment Management sold 25,782 Avita Medical shares in Q2 2022, an estimated $219K.
  • Granahan Investment Management first reported a position in Avita Medical in Q2 2021 and held it in 4 quarters.
  • Granahan Investment Management's Avita Medical position peaked at $282K in Q3 2021.
  • 56 funds tracked by Wall St. Rank held Avita Medical as of Q2 2022.

Based on Granahan Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.